Meeting Mic

Highlights from ASCO Annual Meeting 2024, Leukemia Edition

Listen Later

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 ASCO Annual Meeting with a focus on leukemia, as well as Healio’s top headlines from the meeting.

Jorge E. Cortes, MD, discusses how asciminib demonstrated superior efficacy to standard first-line therapies for certain patients with newly diagnosed chronic myeloid leukemia. :27

Oreofe O. Odejide, MD, MPH, highlights the importance of this study. 3:30

Read the full coverage here:

https://www.healio.com/news/hematology-oncology/20240531/asciminib-may-transform-treatment-paradigm-for-chronic-myeloid-leukemia

New approach ‘redefining what is a suitable donor’ for stem cell transplant

Source: Al Malki MM, et al. Abstract 6503. Presented at: ASCO Annual Meeting; May 30 – June 4, 2024; Chicago.

Disclosures:

Cortes reports research funding to his institution from or consultant/advisory roles with Gilead Sciences, Jazz Pharmaceuticals, Novartis, Pfizer, Takeda and other companies.

...more
View all episodesView all episodes
Download on the App Store
Meeting MicBy Healio
  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

5 ratings

More shows like Meeting Mic

View all
Eye Care Out Loud by Darrell White

Eye Care Out Loud

9 Listeners

Healio Rheuminations by Adam J. Brown, MD

Healio Rheuminations

115 Listeners

Gut Talk by Sameer K. Berry, MD, and William D. Chey, MD

Gut Talk

32 Listeners

Unmasking COVID-19 by Healio

Unmasking COVID-19

30 Listeners

Oncology Overdrive by Shikha Jain, MD

Oncology Overdrive

15 Listeners

Eye Care Insider by Joshua Mali, MD

Eye Care Insider

5 Listeners

Vital Capacity by Abhishek Bhardwaj, MD

Vital Capacity

13 Listeners

Mend the Gap: Equity in Medicine by Healio

Mend the Gap: Equity in Medicine

6 Listeners

Eyeluminaries by John Hovanesian, MD, FACS and Jim Mazzo

Eyeluminaries

5 Listeners